We are live on ! Find out more
SBCWW

SBC Medical Group Warrants

17 hedge funds and large institutions have $1.74M invested in SBC Medical Group Warrants in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1717 (0)

0.69% less ownership

Funds ownership: 42.05%41.36% (-0.69%)

1% less capital invested

Capital invested by funds: $1.76M → $1.74M (-$19.4K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
3
Closed
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change

SBCWW Hedge Fund Activity: Q4 2025 in Review

17 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group Warrants (SBCWW) for Q4 2025, worth a combined $1.74M — down 1.1% from $1.76M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SBCWW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Aristeia Capital, adding an estimated $32.2K. The largest seller was Polar Asset Management Partners, cutting an estimated $17.2K.

  • 17 institutional investors held SBC Medical Group Warrants (SBCWW) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $1.74M of SBC Medical Group Warrants stock for Q4 2025, down 1.1% quarter-over-quarter.
  • 1 fund opened new SBC Medical Group Warrants positions in Q4 2025 and 0 closed out, a net change of +1 holder.
  • The largest SBC Medical Group Warrants buyer in Q4 2025 was Aristeia Capital, an estimated $32.2K added.
  • The largest SBC Medical Group Warrants seller in Q4 2025 was Polar Asset Management Partners, an estimated $17.2K sold.

Based on aggregated 13F filings for Q4 2025.